t-butyloxycarbonyl-methionyl-leucyl-phenylalanine has been researched along with trp-lys-tyr-met-val-met in 1 studies
| Studies (t-butyloxycarbonyl-methionyl-leucyl-phenylalanine) | Trials (t-butyloxycarbonyl-methionyl-leucyl-phenylalanine) | Recent Studies (post-2010) (t-butyloxycarbonyl-methionyl-leucyl-phenylalanine) | Studies (trp-lys-tyr-met-val-met) | Trials (trp-lys-tyr-met-val-met) | Recent Studies (post-2010) (trp-lys-tyr-met-val-met) |
|---|---|---|---|---|---|
| 22 | 0 | 4 | 92 | 1 | 38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bylund, J; Dahlgren, C; Fu, H; Karlsson, J; Stenfeldt, AL; Wennerås, C | 1 |
1 other study(ies) available for t-butyloxycarbonyl-methionyl-leucyl-phenylalanine and trp-lys-tyr-met-val-met
| Article | Year |
|---|---|
Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor.
Topics: Complement C5a; Cyclosporine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophil Activation; Neutrophils; Oligopeptides; Receptors, Formyl Peptide; Receptors, Lipoxin; Signal Transduction; Time Factors | 2007 |